Rhythm Pharmaceuticals Inc (RYTM)
37.98
-0.13
(-0.34%)
USD |
NASDAQ |
Apr 19, 16:00
37.98
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Cash from Operations (TTM): -136.16M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -136.16M |
September 30, 2023 | -140.77M |
June 30, 2023 | -158.51M |
March 31, 2023 | -156.23M |
December 31, 2022 | -173.43M |
September 30, 2022 | -179.90M |
June 30, 2022 | -173.07M |
March 31, 2022 | -166.10M |
December 31, 2021 | -146.00M |
September 30, 2021 | -134.65M |
June 30, 2021 | -121.52M |
March 31, 2021 | -119.41M |
December 31, 2020 | -121.98M |
Date | Value |
---|---|
September 30, 2020 | -125.08M |
June 30, 2020 | -131.65M |
March 31, 2020 | -127.47M |
December 31, 2019 | -122.75M |
September 30, 2019 | -111.51M |
June 30, 2019 | -94.85M |
March 31, 2019 | -81.78M |
December 31, 2018 | -62.06M |
September 30, 2018 | -48.96M |
June 30, 2018 | -40.43M |
March 31, 2018 | -34.10M |
December 31, 2017 | -29.46M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-179.90M
Minimum
Sep 2022
-94.85M
Maximum
Jun 2019
-139.00M
Average
-134.65M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Pfizer Inc | 8.70B |
Insmed Inc | -536.25M |
Altimmune Inc | -75.81M |
Regeneron Pharmaceuticals Inc | 4.594B |
Viking Therapeutics Inc | -73.38M |